b. van arnam a. c. ruzzini c. s. sit h. horn a. pinto- tomas c. r. currie and j. clardy proc.

b. van arnam a. c. ruzzini c. s. sit c. r. currie and j. clardy j. am.

c. jones c. s. jones k. jungmann c. keglerh.

d. bezerra c. c. nascimento n. barbosa rdo d. c. da silva v. m. svedese e. b. silva-nogueira b. s. gomesl.

this modulation of bacterial np biosynthesis by a mycobiont represents an inter- esting addition to the previously established ability of c. albi- cans to produce and exploit the sesquiterpene farnesol.151 interestingly and not unlike the pyochelinpyoverdine case farnesol from the mycobiont suppresses the ability of p. aer- uginosa to produce the antifungal phenazine pyocyanin as well as certain redox-active pyocyanin precursors whose antifungal activity actually surpasses that of pyocyanin.151152 the produc- tion of qs molecules such as 3-oxo-c12-homoserine lactone hsl by the p. aeruginosa is also inhibited by c. albicansgenerated farnesol.151 signicantly the phenzines impair fungal viability.

c. leal c. sheridan r. osinga g. dionisio r. j. rochab.

c. olofsson e. butler p. markowicz c. lindholmlarsson and a. v'asquez int.

47 r. a. arango c. m. carlson c. r. currie b. r. mcdonalda.

sherman k. sivonen m. j. smanski m. sosiostegmann r. d. sussmuth k. tahlan c. m. thomastang a. w. truman m. viaud j. d. walton c. t. walsht.

w. hegarty c. m. guinane r. p. ross c. hill and p. d. cotter f1000research 2016 5 2587.m.

s. donia p. cimermancic c. j. schulze l. c. wieland brown j. martin m. mitreva j. clardy r. g. linington and m. a. fischbach cell 2014 158 1402-1414.j.

zipperer m. c. konnerth c. laux a. berscheid d. janekc.

2016 7 1832.y.-m. chiang k.-h. lee j. f. sanchez n. p. keller and c. c. wang nat.

netzker j. fischer j. weber d. j. mattern c. c. konigv.

c. barnes j. jumpathong s. lumyong k. voigt and c. hertweck chemistry 2016 22 4551-4555.p.

